Pick the most likely subtype of leukemia associated with the following finding?
**Question:** Pick the most likely subtype of leukemia associated with the following finding:
A. Lymphocytic infiltration of the bone marrow
B. Monocytic infiltration of the liver
C. Erythrocytic hyperplasia with megaloblastic changes
D. Plasmacytic infiltration of the kidney
**Correct Answer: C. Erythrocytic hyperplasia with megaloblastic changes**
**Core Concept:**
Leukemia is a group of blood cancers characterized by the uncontrolled proliferation of abnormal white blood cells. Leukemia subtypes can be broadly classified into two categories: Lymphoid leukemia and Myeloid leukemia. Lymphoid leukemia involves lymphocytic cells, while myeloid leukemia involves myeloid cells. Additionally, there are specific subtypes within each category, such as erythrocytic, myelocytic, and lymphocytic.
**Why the Correct Answer is Right:**
In the given question, we are presented with a clinical finding: erythrocytic hyperplasia with megaloblastic changes. Megaloblastic anemia is a type of anemia caused by impaired DNA synthesis in the bone marrow. This type of anemia is commonly seen in myeloblastic leukemia.
**Why Each Wrong Option is Incorrect:**
A. Lymphocytic infiltration of the bone marrow (option A) is a finding in lymphoblastic leukemia, not myeloblastic leukemia.
B. Monocytic infiltration of the liver (option B) is a finding in monocytic leukemia, but the correct answer is based on erythrocytic hyperplasia and megaloblastic changes, not liver involvement.
D. Plasmacytic infiltration of the kidney (option D) is a finding in myeloma, a plasma cell disorder rather than a subtype of leukemia.
**Why the Correct Answer is Right:**
Erythrocytic hyperplasia with megaloblastic changes is a characteristic feature of myeloblastic leukemia, specifically the subgroup of myeloblastic leukemia known as chronic myeloid leukemia (CML). In CML, the abnormal BCR-ABL1 fusion gene, a result of a chromosomal translocation, leads to uncontrolled proliferation of myeloid cells, including erythrocytes, which results in erythrocytic hyperplasia and megaloblastic changes in the bone marrow.
**Clinical Pearl:**
Understanding the clinical features and diagnostic criteria of different subtypes of leukemia is crucial for accurate diagnosis and appropriate management. Megaloblastic changes can be seen in other conditions, but the correct answer is based on the combination of erythrocytic hyperplasia and megaloblastic changes. In this case, it is the presence of these findings in association with myeloblastic leukemia that leads to the correct answer.